1417. Evaluating the Dissonance Between C(max) and AUC with Clinically Utilized Aminoglycoside (AG) Dosing Regimens: Use of Tobramycin (TOB) Against Pseudomonas aeruginosa (PA) as a Case Study

BACKGROUND: Current dogma suggests optimizing AG doses based on peak concentration (C(max)), without consideration of daily drug exposure (AUC(24)). The correlation between attainment of the TOB pharmacokinetic-pharmacodynamic (PK-PD) targets, C(max):MIC and AUC(24):MIC ratio was explored using a TO...

Descripción completa

Detalles Bibliográficos
Autores principales: Onufrak, Nikolas J, Bhavnani, Sujata M, Pogue, Jason M, Rubino, Christopher M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253600/
http://dx.doi.org/10.1093/ofid/ofy210.1248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253600/
http://dx.doi.org/10.1093/ofid/ofy210.1248

Ejemplares similares